BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16190371)

  • 1. [Participation in Swiss mammography screening programmes: key role of physicians].
    Bulliard JL; de Landtsheer JP; Levi F
    Praxis (Bern 1994); 2005 Sep; 94(36):1381-7. PubMed ID: 16190371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reattendance in the Swiss mammography screening pilot programme.
    Bulliard JL; De Landtsheer JP; Levi F
    J Med Screen; 2004; 11(2):59-64. PubMed ID: 15153319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who gets screened, and where: a comparison of organised and opportunistic mammography screening in Geneva, Switzerland.
    Chamot E; Charvet AI; Perneger TV
    Eur J Cancer; 2007 Feb; 43(3):576-84. PubMed ID: 17223542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of women not attending in the Swiss Mammography Screening Pilot Programme.
    Bulliard JL; de Landtsheer JP; Levi F
    Breast; 2004 Aug; 13(4):284-9. PubMed ID: 15325662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting reattendance to the second round of the Maltese national breast screening programme: an analytical descriptive study.
    Marmarà D; Marmarà V; Hubbard G
    BMC Public Health; 2019 Feb; 19(1):189. PubMed ID: 30760275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attendance in the Norwegian Breast Cancer Screening Programme].
    Sebuødegård S; Sagstad S; Hofvind S
    Tidsskr Nor Laegeforen; 2016 Sep; 136(17):1448-51. PubMed ID: 27686204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of false-positive results on reattendance at breast cancer screening programmes in Spain.
    Alamo-Junquera D; Murta-Nascimento C; Macià F; Baré M; Galcerán J; Ascunce N; Zubizarreta R; Salas D; Román R; Castells X; Sala M;
    Eur J Public Health; 2012 Jun; 22(3):404-8. PubMed ID: 21558152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of physicians in mammography referral for older Caribbean women in Canada.
    Hyman I; Singh M; Ahmad F; Austin L; Meana M; George U; Wells LM; Stewart D
    Medscape Womens Health; 2001 Oct; 6(5):6. PubMed ID: 11698928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of Advanced Breast Cancer Stages at Subsequent Participation in Mammography Screening.
    Weigel S; Heindel W; Heidrich J; Heidinger O; Hense HW
    Rofo; 2016 Jan; 188(1):33-7. PubMed ID: 26485700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from the Swiss mammography screening pilot programme.
    Bulliard JL; De Landtsheer JP; Levi F
    Eur J Cancer; 2003 Aug; 39(12):1761-9. PubMed ID: 12888372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The population-based mammography screening programme in Germany: uptake and first experiences of women in 10 federal states].
    Albert US; Kalder M; Schulte H; Klusendick M; Diener J; Schulz-Zehden B; Kopp I; Nass-Griegoleit I
    Gesundheitswesen; 2012 Feb; 74(2):61-70. PubMed ID: 21229475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-attendance in mammography screening and women's social network: a cohort study on the influence of family composition, social support, attitudes and cancer in close relations.
    Manjer ÅR; Emilsson UM; Zackrisson S
    World J Surg Oncol; 2015 Jun; 13():211. PubMed ID: 26130129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring women's experiences during three rounds of breast cancer screening: results from a longitudinal study.
    Drossaert CH; Boer H; Seydel ER
    J Med Screen; 2002; 9(4):168-75. PubMed ID: 12518007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial.
    Hegenscheid K; Hoffmann W; Fochler S; Domin M; Weiss S; Hartmann B; Bick U; Hosten N
    Am J Prev Med; 2011 Oct; 41(4):421-7. PubMed ID: 21961470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gynecologist's role in mammography screening in absence of a public health program.
    Chamot E; Perneger TV
    Arch Gynecol Obstet; 2003 Jun; 268(2):88-93. PubMed ID: 12768296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative attendance, assessment and cancer detection rate over four screening rounds in five English breast-screening programmes: a retrospective study.
    Wallis M; Neilson F; Hogarth H; Whitaker C; Faulkner K
    J Public Health (Oxf); 2007 Sep; 29(3):275-80. PubMed ID: 17522078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reattendance of women for breast cancer screening programs. A review].
    Soler-Michel P; Courtial I; Bremond A
    Rev Epidemiol Sante Publique; 2005 Nov; 53(5):549-67. PubMed ID: 16434928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
    Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
    Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
    Duijm LE; Guit GL; Zaat JO
    Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.